• Ud fra de aktuelt foreliggende data om lav immunogenicitet fandt CHMP yderligere undersøgelser nødvendige for at sikre langtidsbeskyttelse mod Hepatitis B med den aktuelle vaccine fremover.
• Considering the data on low immunogenicity available today, the CHMP identified the need for further studies to ensure long-term protection against Hepatitis B with the current vaccine in future.